{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:33Z","timestamp":1790613813478,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["765274"],"award-info":[{"award-number":["765274"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajog.2022.09.046","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T06:01:59Z","timestamp":1665122519000},"page":"395-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Low-dose aspirin for the\u00a0prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4131-4535","authenticated-orcid":false,"given":"Eleanor M.F.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Giorgione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basky","family":"Thilaganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.09.046_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2022.09.046_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2022.09.046_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006250-200212000-00037","article-title":"Chronic hypertension in pregnancy","volume":"100","author":"Sibai","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib4","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"High Risk of Pre-eclampsia Identification Group. Clinical risk factors for preeclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2022.09.046_bib5","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2022.09.046_bib7","author":"O\u2019Connor"},{"key":"10.1016\/j.ajog.2022.09.046_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.046_bib11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0140-6736(90)91377-M","article-title":"Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension","volume":"335","author":"McParland","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (collaborative low-dose aspirin study in pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of maternal-fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.046_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of maternal-fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.046_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.09.046_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2022.09.046_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2022.09.046_bib22","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2022.09.046_bib23","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2022.09.046_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2022.09.046_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jclinepi.2013.10.019","article-title":"The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index","volume":"67","author":"Walsh","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2022.09.046_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.ajog.2022.09.046_bib28","unstructured":"GRADEpro GDT: GRADEpro guideline development tool. McMaster University and evidence prime. 2022. Available at: gradepro.org. Accessed August 5, 2022."},{"key":"10.1016\/j.ajog.2022.09.046_bib29","author":"Richards"},{"key":"10.1016\/j.ajog.2022.09.046_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10641955.2017.1311340","article-title":"Incidence of superimposed preeclampsia among pregnant Asian women with chronic hypertension","volume":"36","author":"Boriboonhirunsarn","year":"2017","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2022.09.046_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0020-7292(97)00257-9","article-title":"A\u00a0randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia","volume":"60","author":"Byaruhanga","year":"1998","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2022.09.046_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (estudo Colaborativo para Preven\u00e7\u00e3o da Pr\u00e9-eclampsia com Aspirina) Collaborative Group","volume":"103","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062140","article-title":"Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy","volume":"8","author":"Lecarpentier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2022.09.046_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.08.004","article-title":"A\u00a0randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China","volume":"226","author":"Lin","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1471-0528.1996.tb09662.x","article-title":"Perinatal morbidity in chronic hypertension","volume":"103","author":"McCowan","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/jp.2014.214","article-title":"Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study","volume":"35","author":"Moore","year":"2015","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2022.09.046_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14715\/cmb\/2017.63.11.16","article-title":"Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo","volume":"66","author":"Xiang","year":"2020","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.ajog.2022.09.046_bib39","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2022.09.046_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","article-title":"Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis","volume":"129","author":"van Vliet","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.09.046_bib42","first-page":"107","article-title":"Pregnancy and delivery in cardiac disease","volume":"61","author":"Ruys","year":"2013","journal-title":"J\u00a0Cardiol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822008031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822008031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:35:38Z","timestamp":1715232938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822008031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0002937822008031"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.09.046","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose aspirin for the\u00a0prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.09.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}